WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitney, K. D.
Right arrow Articles by McNamara, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitney, K. D.
Right arrow Articles by McNamara, J. O.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2000, 20(19):7307-7316

GluR3 Autoantibodies Destroy Neural Cells in a Complement-Dependent Manner Modulated by Complement Regulatory Proteins

Karl D. Whitney1, 2 and James O. McNamara1, 2, 3, 4

1 Epilepsy Research Laboratory and Departments of 2 Pharmacology and Molecular Cancer Biology and 3 Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, and 4 Durham Veterans Affairs Medical Center, Durham, North Carolina 27705

GluR3 autoantibodies have been implicated in the development of Rasmussen's encephalitis, a rare neurodegenerative disease of humans characterized by epilepsy and degeneration of a single cerebral hemisphere. GluR3 autoantibodies are found in some Rasmussen's encephalitis patients, and GluR3 antibodies raised in rabbits destroy cultured cortical cells in a complement-dependent manner. In this study, the cellular targets of anti-GluR3 antisera-mediated cytotoxicity were examined in mixed primary neuronal-glial cultures of rat cortex. Unexpectedly, astrocytes were the principal target of the cytotoxic effects as assessed by immunohistochemistry and lactate dehydrogenase activity; neurons were destroyed to a lesser extent. Astrocyte vulnerability was rescued by transfection with complement regulatory proteins, and neuronal resistance was defeated by impairing complement regulatory protein function. Astrocyte death may occur in Rasmussen's encephalitis, and destruction of this cell type may play a critical role in the progression of this disorder. The present findings suggest complement regulatory protein expression may in part determine the nature and severity of Rasmussen's encephalitis and other complement-dependent nervous system diseases and thus underscore the need for a systematic investigation of the expression of all known complement regulatory proteins in healthy and diseased nervous system tissues.

Key words: GluR3 autoantibody; Rasmussen's encephalitis; complement; complement regulatory protein; autoimmunity; epilepsy; glutamate receptor


Copyright © 2000 Society for Neuroscience  0270-6474/00/20197307-10$05.00/0


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Ganor, V. I. Teichberg, and M. Levite
TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage
J. Immunol., January 15, 2007; 178(2): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
B. Tziperman, B.-Z. Garty, N. Schoenfeld, V. Hoffer, N. Watemberg, D. Lev, Y. Ganor, M. Levite, and T. Lerman-Sagie
Acute Intermittent Porphyria, Rasmussen Encephalitis, or Both?
J Child Neurol, January 1, 2007; 22(1): 99 - 105.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
P. Roll, G. Rudolf, S. Pereira, B. Royer, I. E. Scheffer, A. Massacrier, M.-P. Valenti, N. Roeckel-Trevisiol, S. Jamali, C. Beclin, et al.
SRPX2 mutations in disorders of language cortex and cognition
Hum. Mol. Genet., April 1, 2006; 15(7): 1195 - 1207.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Jamali, F. Bartolomei, A. Robaglia-Schlupp, A. Massacrier, J.-C. Peragut, J. Regis, H. Dufour, R. Ravid, P. Roll, S. Pereira, et al.
Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex
Brain, March 1, 2006; 129(3): 625 - 641.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al.
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement
Brain, March 1, 2005; 128(3): 454 - 471.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, K. McKnight, J. H. Cross, I. K. Hart, A. Roubertie, J. Valmier, et al.
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis
Neurology, July 13, 2004; 63(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ganor, M. Besser, N. Ben-Zakay, T. Unger, and M. Levite
Human T Cells Express a Functional Ionotropic Glutamate Receptor GluR3, and Glutamate by Itself Triggers Integrin-Mediated Adhesion to Laminin and Fibronectin and Chemotactic Migration
J. Immunol., April 15, 2003; 170(8): 4362 - 4372.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z.-Q. Xiong, W. Qian, K. Suzuki, and J. O. McNamara
Formation of Complement Membrane Attack Complex in Mammalian Cerebral Cortex Evokes Seizures and Neurodegeneration
J. Neurosci., February 1, 2003; 23(3): 955 - 960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. D. Whitney, M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J. Numerick, T. K. Tippin, J. G. Wilson, D. A. Winegar, and S. A. Kliewer
Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
Mol. Endocrinol., June 1, 2002; 16(6): 1378 - 1385.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.E. Baranzini, K. Laxer, R. Saketkhoo, M.K. Elkins, J.M. Parent, R. Mantegazza, and J.R. Oksenberg
Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis
Neurology, March 12, 2002; 58(5): 709 - 716.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. G. Bien, H. Urbach, M. Deckert, J. Schramm, O. D. Wiestler, H. Lassmann, and C. E. Elger
Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology
Neurology, January 22, 2002; 58(2): 250 - 257.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-